Global Meningococcal Disease Drugs Market Growth 2025-2031

October 2025 | 113 pages | ID: G2F58ED08E7EN
LP Information

Abstracts

The global Meningococcal Disease Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Meningococcal disease drugs refer to medications used to treat meningococcal infections caused by Neisseria meningitidis.

The market for meningococcal disease drugs is driven by the demand for effective antimicrobial therapies to treat bacterial meningitis and sepsis. The market's growth is also influenced by the emphasis on vaccination and preventive measures to control meningococcal disease outbreaks.

LP Information, Inc. (LPI) ' newest research report, the ?Meningococcal Disease Drugs Industry Forecast? looks at past sales and reviews total world Meningococcal Disease Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningococcal Disease Drugs sales for 2025 through 2031. With Meningococcal Disease Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Disease Drugs industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Disease Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningococcal Disease Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Meningococcal Disease Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Disease Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Disease Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Injectable
• Oral

Segmentation by Application:

• Hospitals
• Drugstores
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer
• GlaxoSmithKline
• Sanofi Pasteur
• Novartis
• Merck Sharp & Dohme
• Hebei Hejia Pharmaceutical Technology Group Co., Ltd
• Shandong Jincheng Pharmaceutical Group Co.,ltd.
• Apeloa Pharmaceutical Co.,Ltd.
• Yiling Pharmaceutical
• Baiyunshan Pharmaceutical
• SSY Group Limited
• Lukang Pharmaceutical Co.,Ltd.
• North China Pharmaceutical Company Ltd.
• Harbin Pharmaceutical Group Co.,Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Meningococcal Disease Drugs market?
What factors are driving Meningococcal Disease Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningococcal Disease Drugs market opportunities vary by end market size?
How does Meningococcal Disease Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Disease Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Meningococcal Disease Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Meningococcal Disease Drugs by Country/Region, 2020, 2024 & 2031
2.2 Meningococcal Disease Drugs Segment by Type
  2.2.1 Injectable
  2.2.2 Oral
2.3 Meningococcal Disease Drugs Sales by Type
  2.3.1 Global Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Meningococcal Disease Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Meningococcal Disease Drugs Sale Price by Type (2020-2025)
2.4 Meningococcal Disease Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Drugstores
  2.4.3 Others
2.5 Meningococcal Disease Drugs Sales by Application
  2.5.1 Global Meningococcal Disease Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Meningococcal Disease Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Meningococcal Disease Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Meningococcal Disease Drugs Breakdown Data by Company
  3.1.1 Global Meningococcal Disease Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Meningococcal Disease Drugs Sales Market Share by Company (2020-2025)
3.2 Global Meningococcal Disease Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Meningococcal Disease Drugs Revenue by Company (2020-2025)
  3.2.2 Global Meningococcal Disease Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Meningococcal Disease Drugs Sale Price by Company
3.4 Key Manufacturers Meningococcal Disease Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Meningococcal Disease Drugs Product Location Distribution
  3.4.2 Players Meningococcal Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MENINGOCOCCAL DISEASE DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Meningococcal Disease Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Meningococcal Disease Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Meningococcal Disease Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Meningococcal Disease Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Meningococcal Disease Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Meningococcal Disease Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Meningococcal Disease Drugs Sales Growth
4.4 APAC Meningococcal Disease Drugs Sales Growth
4.5 Europe Meningococcal Disease Drugs Sales Growth
4.6 Middle East & Africa Meningococcal Disease Drugs Sales Growth

5 AMERICAS

5.1 Americas Meningococcal Disease Drugs Sales by Country
  5.1.1 Americas Meningococcal Disease Drugs Sales by Country (2020-2025)
  5.1.2 Americas Meningococcal Disease Drugs Revenue by Country (2020-2025)
5.2 Americas Meningococcal Disease Drugs Sales by Type (2020-2025)
5.3 Americas Meningococcal Disease Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Meningococcal Disease Drugs Sales by Region
  6.1.1 APAC Meningococcal Disease Drugs Sales by Region (2020-2025)
  6.1.2 APAC Meningococcal Disease Drugs Revenue by Region (2020-2025)
6.2 APAC Meningococcal Disease Drugs Sales by Type (2020-2025)
6.3 APAC Meningococcal Disease Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Meningococcal Disease Drugs by Country
  7.1.1 Europe Meningococcal Disease Drugs Sales by Country (2020-2025)
  7.1.2 Europe Meningococcal Disease Drugs Revenue by Country (2020-2025)
7.2 Europe Meningococcal Disease Drugs Sales by Type (2020-2025)
7.3 Europe Meningococcal Disease Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Disease Drugs by Country
  8.1.1 Middle East & Africa Meningococcal Disease Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Meningococcal Disease Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Meningococcal Disease Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Meningococcal Disease Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs
10.3 Manufacturing Process Analysis of Meningococcal Disease Drugs
10.4 Industry Chain Structure of Meningococcal Disease Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Meningococcal Disease Drugs Distributors
11.3 Meningococcal Disease Drugs Customer

12 WORLD FORECAST REVIEW FOR MENINGOCOCCAL DISEASE DRUGS BY GEOGRAPHIC REGION

12.1 Global Meningococcal Disease Drugs Market Size Forecast by Region
  12.1.1 Global Meningococcal Disease Drugs Forecast by Region (2026-2031)
  12.1.2 Global Meningococcal Disease Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Meningococcal Disease Drugs Forecast by Type (2026-2031)
12.7 Global Meningococcal Disease Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Meningococcal Disease Drugs Product Portfolios and Specifications
  13.1.3 Pfizer Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Meningococcal Disease Drugs Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Sanofi Pasteur
  13.3.1 Sanofi Pasteur Company Information
  13.3.2 Sanofi Pasteur Meningococcal Disease Drugs Product Portfolios and Specifications
  13.3.3 Sanofi Pasteur Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sanofi Pasteur Main Business Overview
  13.3.5 Sanofi Pasteur Latest Developments
13.4 Novartis
  13.4.1 Novartis Company Information
  13.4.2 Novartis Meningococcal Disease Drugs Product Portfolios and Specifications
  13.4.3 Novartis Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Novartis Main Business Overview
  13.4.5 Novartis Latest Developments
13.5 Merck Sharp & Dohme
  13.5.1 Merck Sharp & Dohme Company Information
  13.5.2 Merck Sharp & Dohme Meningococcal Disease Drugs Product Portfolios and Specifications
  13.5.3 Merck Sharp & Dohme Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Merck Sharp & Dohme Main Business Overview
  13.5.5 Merck Sharp & Dohme Latest Developments
13.6 Hebei Hejia Pharmaceutical Technology Group Co., Ltd
  13.6.1 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Company Information
  13.6.2 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product Portfolios and Specifications
  13.6.3 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Main Business Overview
  13.6.5 Hebei Hejia Pharmaceutical Technology Group Co., Ltd Latest Developments
13.7 Shandong Jincheng Pharmaceutical Group Co.,ltd.
  13.7.1 Shandong Jincheng Pharmaceutical Group Co.,ltd. Company Information
  13.7.2 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
  13.7.3 Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Shandong Jincheng Pharmaceutical Group Co.,ltd. Main Business Overview
  13.7.5 Shandong Jincheng Pharmaceutical Group Co.,ltd. Latest Developments
13.8 Apeloa Pharmaceutical Co.,Ltd.
  13.8.1 Apeloa Pharmaceutical Co.,Ltd. Company Information
  13.8.2 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
  13.8.3 Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Apeloa Pharmaceutical Co.,Ltd. Main Business Overview
  13.8.5 Apeloa Pharmaceutical Co.,Ltd. Latest Developments
13.9 Yiling Pharmaceutical
  13.9.1 Yiling Pharmaceutical Company Information
  13.9.2 Yiling Pharmaceutical Meningococcal Disease Drugs Product Portfolios and Specifications
  13.9.3 Yiling Pharmaceutical Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Yiling Pharmaceutical Main Business Overview
  13.9.5 Yiling Pharmaceutical Latest Developments
13.10 Baiyunshan Pharmaceutical
  13.10.1 Baiyunshan Pharmaceutical Company Information
  13.10.2 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product Portfolios and Specifications
  13.10.3 Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Baiyunshan Pharmaceutical Main Business Overview
  13.10.5 Baiyunshan Pharmaceutical Latest Developments
13.11 SSY Group Limited
  13.11.1 SSY Group Limited Company Information
  13.11.2 SSY Group Limited Meningococcal Disease Drugs Product Portfolios and Specifications
  13.11.3 SSY Group Limited Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 SSY Group Limited Main Business Overview
  13.11.5 SSY Group Limited Latest Developments
13.12 Lukang Pharmaceutical Co.,Ltd.
  13.12.1 Lukang Pharmaceutical Co.,Ltd. Company Information
  13.12.2 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
  13.12.3 Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Lukang Pharmaceutical Co.,Ltd. Main Business Overview
  13.12.5 Lukang Pharmaceutical Co.,Ltd. Latest Developments
13.13 North China Pharmaceutical Company Ltd.
  13.13.1 North China Pharmaceutical Company Ltd. Company Information
  13.13.2 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
  13.13.3 North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 North China Pharmaceutical Company Ltd. Main Business Overview
  13.13.5 North China Pharmaceutical Company Ltd. Latest Developments
13.14 Harbin Pharmaceutical Group Co.,Ltd.
  13.14.1 Harbin Pharmaceutical Group Co.,Ltd. Company Information
  13.14.2 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
  13.14.3 Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Harbin Pharmaceutical Group Co.,Ltd. Main Business Overview
  13.14.5 Harbin Pharmaceutical Group Co.,Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Disease Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Meningococcal Disease Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injectable
Table 4. Major Players of Oral
Table 5. Global Meningococcal Disease Drugs Sales by Type (2020-2025) & (Kiloton)
Table 6. Global Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
Table 7. Global Meningococcal Disease Drugs Revenue by Type (2020-2025) & ($ million)
Table 8. Global Meningococcal Disease Drugs Revenue Market Share by Type (2020-2025)
Table 9. Global Meningococcal Disease Drugs Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Meningococcal Disease Drugs Sale by Application (2020-2025) & (Kiloton)
Table 11. Global Meningococcal Disease Drugs Sale Market Share by Application (2020-2025)
Table 12. Global Meningococcal Disease Drugs Revenue by Application (2020-2025) & ($ million)
Table 13. Global Meningococcal Disease Drugs Revenue Market Share by Application (2020-2025)
Table 14. Global Meningococcal Disease Drugs Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Meningococcal Disease Drugs Sales by Company (2020-2025) & (Kiloton)
Table 16. Global Meningococcal Disease Drugs Sales Market Share by Company (2020-2025)
Table 17. Global Meningococcal Disease Drugs Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Meningococcal Disease Drugs Revenue Market Share by Company (2020-2025)
Table 19. Global Meningococcal Disease Drugs Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Meningococcal Disease Drugs Producing Area Distribution and Sales Area
Table 21. Players Meningococcal Disease Drugs Products Offered
Table 22. Meningococcal Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Meningococcal Disease Drugs Sales by Geographic Region (2020-2025) & (Kiloton)
Table 26. Global Meningococcal Disease Drugs Sales Market Share Geographic Region (2020-2025)
Table 27. Global Meningococcal Disease Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Meningococcal Disease Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Meningococcal Disease Drugs Sales by Country/Region (2020-2025) & (Kiloton)
Table 30. Global Meningococcal Disease Drugs Sales Market Share by Country/Region (2020-2025)
Table 31. Global Meningococcal Disease Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Meningococcal Disease Drugs Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Meningococcal Disease Drugs Sales by Country (2020-2025) & (Kiloton)
Table 34. Americas Meningococcal Disease Drugs Sales Market Share by Country (2020-2025)
Table 35. Americas Meningococcal Disease Drugs Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Meningococcal Disease Drugs Sales by Type (2020-2025) & (Kiloton)
Table 37. Americas Meningococcal Disease Drugs Sales by Application (2020-2025) & (Kiloton)
Table 38. APAC Meningococcal Disease Drugs Sales by Region (2020-2025) & (Kiloton)
Table 39. APAC Meningococcal Disease Drugs Sales Market Share by Region (2020-2025)
Table 40. APAC Meningococcal Disease Drugs Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Meningococcal Disease Drugs Sales by Type (2020-2025) & (Kiloton)
Table 42. APAC Meningococcal Disease Drugs Sales by Application (2020-2025) & (Kiloton)
Table 43. Europe Meningococcal Disease Drugs Sales by Country (2020-2025) & (Kiloton)
Table 44. Europe Meningococcal Disease Drugs Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Meningococcal Disease Drugs Sales by Type (2020-2025) & (Kiloton)
Table 46. Europe Meningococcal Disease Drugs Sales by Application (2020-2025) & (Kiloton)
Table 47. Middle East & Africa Meningococcal Disease Drugs Sales by Country (2020-2025) & (Kiloton)
Table 48. Middle East & Africa Meningococcal Disease Drugs Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Meningococcal Disease Drugs Sales by Type (2020-2025) & (Kiloton)
Table 50. Middle East & Africa Meningococcal Disease Drugs Sales by Application (2020-2025) & (Kiloton)
Table 51. Key Market Drivers & Growth Opportunities of Meningococcal Disease Drugs
Table 52. Key Market Challenges & Risks of Meningococcal Disease Drugs
Table 53. Key Industry Trends of Meningococcal Disease Drugs
Table 54. Meningococcal Disease Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Meningococcal Disease Drugs Distributors List
Table 57. Meningococcal Disease Drugs Customer List
Table 58. Global Meningococcal Disease Drugs Sales Forecast by Region (2026-2031) & (Kiloton)
Table 59. Global Meningococcal Disease Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Meningococcal Disease Drugs Sales Forecast by Country (2026-2031) & (Kiloton)
Table 61. Americas Meningococcal Disease Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Meningococcal Disease Drugs Sales Forecast by Region (2026-2031) & (Kiloton)
Table 63. APAC Meningococcal Disease Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Meningococcal Disease Drugs Sales Forecast by Country (2026-2031) & (Kiloton)
Table 65. Europe Meningococcal Disease Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Meningococcal Disease Drugs Sales Forecast by Country (2026-2031) & (Kiloton)
Table 67. Middle East & Africa Meningococcal Disease Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Meningococcal Disease Drugs Sales Forecast by Type (2026-2031) & (Kiloton)
Table 69. Global Meningococcal Disease Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Meningococcal Disease Drugs Sales Forecast by Application (2026-2031) & (Kiloton)
Table 71. Global Meningococcal Disease Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Meningococcal Disease Drugs Product Portfolios and Specifications
Table 74. Pfizer Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. GlaxoSmithKline Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Meningococcal Disease Drugs Product Portfolios and Specifications
Table 79. GlaxoSmithKline Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments
Table 82. Sanofi Pasteur Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Pasteur Meningococcal Disease Drugs Product Portfolios and Specifications
Table 84. Sanofi Pasteur Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Sanofi Pasteur Main Business
Table 86. Sanofi Pasteur Latest Developments
Table 87. Novartis Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Meningococcal Disease Drugs Product Portfolios and Specifications
Table 89. Novartis Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Merck Sharp & Dohme Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Sharp & Dohme Meningococcal Disease Drugs Product Portfolios and Specifications
Table 94. Merck Sharp & Dohme Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Merck Sharp & Dohme Main Business
Table 96. Merck Sharp & Dohme Latest Developments
Table 97. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Product Portfolios and Specifications
Table 99. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Main Business
Table 101. Hebei Hejia Pharmaceutical Technology Group Co., Ltd Latest Developments
Table 102. Shandong Jincheng Pharmaceutical Group Co.,ltd. Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
Table 104. Shandong Jincheng Pharmaceutical Group Co.,ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Shandong Jincheng Pharmaceutical Group Co.,ltd. Main Business
Table 106. Shandong Jincheng Pharmaceutical Group Co.,ltd. Latest Developments
Table 107. Apeloa Pharmaceutical Co.,Ltd. Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
Table 109. Apeloa Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Apeloa Pharmaceutical Co.,Ltd. Main Business
Table 111. Apeloa Pharmaceutical Co.,Ltd. Latest Developments
Table 112. Yiling Pharmaceutical Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Yiling Pharmaceutical Meningococcal Disease Drugs Product Portfolios and Specifications
Table 114. Yiling Pharmaceutical Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Yiling Pharmaceutical Main Business
Table 116. Yiling Pharmaceutical Latest Developments
Table 117. Baiyunshan Pharmaceutical Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Product Portfolios and Specifications
Table 119. Baiyunshan Pharmaceutical Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Baiyunshan Pharmaceutical Main Business
Table 121. Baiyunshan Pharmaceutical Latest Developments
Table 122. SSY Group Limited Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. SSY Group Limited Meningococcal Disease Drugs Product Portfolios and Specifications
Table 124. SSY Group Limited Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. SSY Group Limited Main Business
Table 126. SSY Group Limited Latest Developments
Table 127. Lukang Pharmaceutical Co.,Ltd. Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
Table 129. Lukang Pharmaceutical Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 130. Lukang Pharmaceutical Co.,Ltd. Main Business
Table 131. Lukang Pharmaceutical Co.,Ltd. Latest Developments
Table 132. North China Pharmaceutical Company Ltd. Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
Table 134. North China Pharmaceutical Company Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 135. North China Pharmaceutical Company Ltd. Main Business
Table 136. North China Pharmaceutical Company Ltd. Latest Developments
Table 137. Harbin Pharmaceutical Group Co.,Ltd. Basic Information, Meningococcal Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Product Portfolios and Specifications
Table 139. Harbin Pharmaceutical Group Co.,Ltd. Meningococcal Disease Drugs Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 140. Harbin Pharmaceutical Group Co.,Ltd. Main Business
Table 141. Harbin Pharmaceutical Group Co.,Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Meningococcal Disease Drugs
Figure 2. Meningococcal Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Disease Drugs Sales Growth Rate 2020-2031 (Kiloton)
Figure 7. Global Meningococcal Disease Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Meningococcal Disease Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Meningococcal Disease Drugs Sales Market Share by Country/Region (2024)
Figure 10. Meningococcal Disease Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injectable
Figure 12. Product Picture of Oral
Figure 13. Global Meningococcal Disease Drugs Sales Market Share by Type in 2025
Figure 14. Global Meningococcal Disease Drugs Revenue Market Share by Type (2020-2025)
Figure 15. Meningococcal Disease Drugs Consumed in Hospitals
Figure 16. Global Meningococcal Disease Drugs Market: Hospitals (2020-2025) & (Kiloton)
Figure 17. Meningococcal Disease Drugs Consumed in Drugstores
Figure 18. Global Meningococcal Disease Drugs Market: Drugstores (2020-2025) & (Kiloton)
Figure 19. Meningococcal Disease Drugs Consumed in Others
Figure 20. Global Meningococcal Disease Drugs Market: Others (2020-2025) & (Kiloton)
Figure 21. Global Meningococcal Disease Drugs Sale Market Share by Application (2024)
Figure 22. Global Meningococcal Disease Drugs Revenue Market Share by Application in 2025
Figure 23. Meningococcal Disease Drugs Sales by Company in 2025 (Kiloton)
Figure 24. Global Meningococcal Disease Drugs Sales Market Share by Company in 2025
Figure 25. Meningococcal Disease Drugs Revenue by Company in 2025 ($ millions)
Figure 26. Global Meningococcal Disease Drugs Revenue Market Share by Company in 2025
Figure 27. Global Meningococcal Disease Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Meningococcal Disease Drugs Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Meningococcal Disease Drugs Sales 2020-2025 (Kiloton)
Figure 30. Americas Meningococcal Disease Drugs Revenue 2020-2025 ($ millions)
Figure 31. APAC Meningococcal Disease Drugs Sales 2020-2025 (Kiloton)
Figure 32. APAC Meningococcal Disease Drugs Revenue 2020-2025 ($ millions)
Figure 33. Europe Meningococcal Disease Drugs Sales 2020-2025 (Kiloton)
Figure 34. Europe Meningococcal Disease Drugs Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Meningococcal Disease Drugs Sales 2020-2025 (Kiloton)
Figure 36. Middle East & Africa Meningococcal Disease Drugs Revenue 2020-2025 ($ millions)
Figure 37. Americas Meningococcal Disease Drugs Sales Market Share by Country in 2025
Figure 38. Americas Meningococcal Disease Drugs Revenue Market Share by Country (2020-2025)
Figure 39. Americas Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
Figure 40. Americas Meningococcal Disease Drugs Sales Market Share by Application (2020-2025)
Figure 41. United States Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Meningococcal Disease Drugs Sales Market Share by Region in 2025
Figure 46. APAC Meningococcal Disease Drugs Revenue Market Share by Region (2020-2025)
Figure 47. APAC Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
Figure 48. APAC Meningococcal Disease Drugs Sales Market Share by Application (2020-2025)
Figure 49. China Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. India Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Meningococcal Disease Drugs Sales Market Share by Country in 2025
Figure 57. Europe Meningococcal Disease Drugs Revenue Market Share by Country (2020-2025)
Figure 58. Europe Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
Figure 59. Europe Meningococcal Disease Drugs Sales Market Share by Application (2020-2025)
Figure 60. Germany Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. France Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Meningococcal Disease Drugs Sales Market Share by Application (2020-2025)
Figure 68. Egypt Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Meningococcal Disease Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Meningococcal Disease Drugs in 2025
Figure 74. Manufacturing Process Analysis of Meningococcal Disease Drugs
Figure 75. Industry Chain Structure of Meningococcal Disease Drugs
Figure 76. Channels of Distribution
Figure 77. Global Meningococcal Disease Drugs Sales Market Forecast by Region (2026-2031)
Figure 78. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Meningococcal Disease Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Meningococcal Disease Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Meningococcal Disease Drugs Revenue Market Share Forecast by Application (2026-2031)